The Journal of Urology
Volume 182, Issue 5 , Pages 2219-2225 , November 2009

Increased Low Density Lipoprotein and Increased Likelihood of Positive Prostate Biopsy in Black Americans

  • Kelvin A. Moses

      Affiliations

    • Department of Urology, Atlanta Veterans Affairs Medical Center, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Department of Urology, Emory University School of Medicine, Emory University, Atlanta, Georgia
  • ,
  • Thura T. Abd

      Affiliations

    • Department of Urology, Atlanta Veterans Affairs Medical Center, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Department of Urology, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
  • ,
  • Michael Goodman

      Affiliations

    • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
  • ,
  • Wayland Hsiao

      Affiliations

    • Department of Urology, Atlanta Veterans Affairs Medical Center, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Department of Urology, Emory University School of Medicine, Emory University, Atlanta, Georgia
  • ,
  • John A. Hall

      Affiliations

    • Department of Urology, Emory University School of Medicine, Emory University, Atlanta, Georgia
  • ,
  • Fray F. Marshall

      Affiliations

    • Department of Urology, Atlanta Veterans Affairs Medical Center, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Department of Urology, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Financial interest and/or other relationship with American Urological Association.
  • ,
  • John A. Petros

      Affiliations

    • Department of Urology, Atlanta Veterans Affairs Medical Center, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Department of Urology, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Emory University, Atlanta, Georgia
  • ,
  • Muta M. Issa

      Affiliations

    • Department of Urology, Atlanta Veterans Affairs Medical Center, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Department of Urology, Emory University School of Medicine, Emory University, Atlanta, Georgia
    • Corresponding Author InformationCorrespondence: Department of Urology, Atlanta Veterans Affairs Medical Center (112), 1670 Clairmont Rd., Northeast, Decatur, Georgia 30033 (telephone: 404-728-4144; FAX: 404-329-2201)

Received 16 March 2009

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71
  2. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers (The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group). N Engl J Med. 1994;330:1029
  3. Helzlsouer KJ, Huang HY, Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000;92:2018
  4. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39
  5. Van Patten CL, de Boer JG, Tomlinson Guns ES. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol. 2008;180:2314
  6. Marks LS, Kojima M, Demarzo A, et al. Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue. Urology. 2004;64:765
  7. Moradi T, Delfino RJ, Bergstrom SR, et al. Cancer risk among Scandinavian immigrants in the US and Scandinavian residents compared with US whites, 1973-89. Eur J Cancer Prev. 1998;7:117
  8. Freedland SJ, Aronson WJ, Kane CJ, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol. 2004;22:446
  9. Freedland SJ, Partin AW. Obesity and prostate cancer detection and progression. Rev Urol. 2004;6:214
  10. Farwell WR, Scranton RE, Lawler EV, et al. The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst. 2008;100:134
  11. Graaf MR, Beiderbeck AB, Egberts AC, et al. The risk of cancer in users of statins. J Clin Oncol. 2004;22:2388
  12. Shannon J, Tewoderos S, Garzotto M, et al. Statins and prostate cancer risk: a case-control study. Am J Epidemiol. 2005;162:318
  13. Demierre MF, Higgins PD, Gruber SB, et al. Statins and cancer prevention. Nat Rev Cancer. 2005;5:930
  14. Kleinbaum DG, Klein M, Pryor ER, et al. Logistic Regression: A Self-Learning Text: Statistics for Biology and Health. New York: Springer; 2002;pp xiv and 513
  15. DeLancey JO, Thun MJ, Jemal A, et al. Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev. 2008;17:2908
  16. Pettaway CA, Troncoso P, Ramirez EI, et al. Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol. 1998;160:437
  17. Powell IJ. Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol. 2007;177:444
  18. Powell IJ, Dey J, Dudley A, et al. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis. Urology. 2002;59:907
  19. Powell IJ, Heilbrun L, Littrup PL, et al. Outcome of African American men screened for prostate cancer: the Detroit Education and Early Detection Study. J Urol. 1997;158:146
  20. Gaston KE, Kim D, Singh S, et al. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol. 2003;170:990
  21. Freeman MR, Solomon KR. Cholesterol and prostate cancer. J Cell Biochem. 2004;91:54
  22. Guyton JR, Dahlen GH, Patsch W, et al. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis. 1985;5:265
  23. Marcovina SM, Albers JJ, Wijsman E, et al. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J Lipid Res. 1996;37:2569
  24. Paultre F, Pearson TA, Weil HF, et al. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol. 2000;20:2619
  25. Hager MH, Solomon KR, Freeman MR. The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care. 2006;9:379
  26. Lee SJ, Ha MJ, Lee J, et al. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem. 1998;273:10618
  27. Marcelli M, Cunningham GR, Haidacher SJ, et al. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 1998;58:76
  28. Porstmann T, Griffiths B, Chung YL, et al. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene. 2005;24:6465
  29. Spangler E, Zeigler-Johnson CM, Coomes M, et al. Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men. J Urol. 2007;178:1939;discussion 1945
  30. Wuermli L, Joerger M, Henz S, et al. Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis. 2005;8:316

 Study received approval from the Atlanta VA Medical Center research and development committee, and Emory University institutional review board.

PII: S0022-5347(09)01768-6

doi: 10.1016/j.juro.2009.07.039

The Journal of Urology
Volume 182, Issue 5 , Pages 2219-2225 , November 2009